argenx Neurology
Avatar

How to Administer and Use the MG-ADL Scale in Clinical Practice

By argenx Neurology FEATURING James F. Howard Jr
By argenx Neurology FEATURING James F. Howard Jr
308 views
September 5, 2024

© 2024 argenx US-VYV-24-00377v1 08/2024. All Rights Reserved.

Comments are disabled for this content.

Featured Video

05:14
argenx Neurology

Understanding Individualized Dosing of Two Treatments for Adult Pati…

Feat. N. J. Silvestri

Featured Video

09:17
argenx Neurology

Considerations for Treatment of Adult Patients with Anti-AChR Antibo…

Feat. J. Durrani

Related Content

AUTOPLAY
07:31
argenx Neurology

The MG-ADL Scale as a Clinical Tool: The Power of Patient Perspective

Feat. S. Muppidi
09:17
argenx Neurology

Considerations for Treatment of Adult Patients with Anti-AChR Antibo…

Feat. J. Durrani
05:14
argenx Neurology

Understanding Individualized Dosing of Two Treatments for Adult Pati…

Feat. N. J. Silvestri
50:07
ZINCARE

Overview of Neuromuscular Disorders

Feat. S. Zimba
26:58
Constantine Farmakidis

Overview of Rozanolixizumab

30:04
NYU Langone

Myasthenia Gravis: Treatment Update

Feat. J. M. Bhatt
33:53
Ghazala Hayat

Antibodies in Myasthenia Gravis: How to Interpret It

06:51
Henry J. Kaminski

Measuring Overall Severity of Myasthenia Gravis: Evidence for the Ad…

07:31
argenx Neurology

The MG-ADL Scale as a Clinical Tool: The Power of Patient Perspective

Feat. S. Muppidi
23:36
Raed Behbehani

Ocular Myasthenia Gravis: A Current Overview

40:06
Diana Greene-Chandos

Neuromuscular Disorders and Spinal Cord Injury in the ICU: Diagnosis…

42:22
Houston Methodist

Advances in Treatments for Myasthenia Gravis

Feat. E. Greene
27:47
Alessio Sarnataro

EAN 2024 Insights: Current Updates in Myasthenia Gravis

29:20
Houston Methodist

2023 Overview of Myasthenia Gravis

Feat. B. Liao
19:54
Ileana Howard

Respiratory Considerations in Neuromuscular Disease

47:25
Houston Methodist

Respiratory Issues in Myasthenic Disease and Management

Feat. M. Cao
16:16
Alexis A. Lizarraga

Treatment Approach in Patients With Myasthenia Gravis

09:00
Katherine C. Dodd

Mycophenolate and Methotrexate Are Better Tolerated Than Azathioprin…

48:05
Houston Methodist

Emerging Therapies for Neuromuscular Diseases in 2021: ALS, Dystroph…

Feat. E. Greene
48:34
Swedish

Myasthenia Gravis and Other Neuromuscular Junction Disorders

Feat. C. Edmundson